Gall Bladder Cancer Clinical Trials

A listing of Gall Bladder Cancer medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 44 clinical trials
Adoptive Transfer of Tumor Infiltrating Lymphocytes for Biliary Tract Cancers

patients with biliary tract cancers (BTC), including cholangiocarcinoma (both intrahepatic and extrahepatic) and gallbladder cancer, who are and are physically able to tolerate non-myeloablative

gilbert's syndrome
hepatitis b antigen
biliary tract cancer
cholangiocarcinoma
carcinoma
  • 26 views
  • 12 Feb, 2021
  • 1 location
Testing the Combination of New Anti-cancer Drug Peposertib With Avelumab and Radiation Therapy for Advanced/Metastatic Solid Tumors and Hepatobiliary Malignancies

This phase I/II trial studies the best dose and side effects of peposertib and to see how well it works with avelumab and hypofractionated radiation therapy in treating patients with solid tumors and hepatobiliary malignancies that have spread to other places in the body (advanced/metastatic). Peposertib may stop the growth …

anti-cancer agents
nedisertib
tumor cells
metastasis
neutrophil count
  • 129 views
  • 27 Jun, 2021
  • 5 locations
Behavioral Weight Loss Program for Cancer Survivors in Maryland

Behavioral Weight Loss for Overweight and Obese Cancer Survivors in Maryland: A Demonstration Project

cancer
breast cancer
tamoxifen
  • 0 views
  • 25 Jan, 2021
  • 1 location
A Study of Metastatic Gastrointestinal Cancers Treated With Tumor Infiltrating Lymphocytes in Which the Gene Encoding the Intracellular Immune Checkpoint CISH Is Inhibited Using CRISPR Genetic Engineering

A clinical trial to assess the safety and efficacy of genetically-engineered, neoantigen-specific Tumor Infiltrating Lymphocytes (TIL) in which the intracellular immune checkpoint CISH has been inhibited using CRISPR gene editing for the treatment of Gastro-Intestinal (GI) Cancer.

hepatitis b antigen
immunoglobulin
aldesleukin
filgrastim
measurable disease
  • 35 views
  • 30 Aug, 2021
  • 1 location
Dasatinib in Preventing Oxaliplatin-Induced Peripheral Neuropathy in Patients With Colorectal Cancer Receiving FOLFOX and Bevacizumab

This phase Ib trial studies side effects and best dose of dasatinib in preventing oxaliplatin-induced peripheral neuropathy in patients with gastrointestinal cancers who are receiving FOLFOX regimen with or without bevacizumab. Drugs used in chemotherapy, such as leucovorin, fluorouracil, and oxaliplatin (FOLFOX regimen), work in different ways to stop the …

calcium
tumor cells
folfox regimen
immunomodulator
immunostimulants
  • 0 views
  • 16 Jul, 2021
  • 1 location
Study of Seribantumab in Adult Patients With NRG1 Gene Fusion Positive Advanced Solid Tumors

This study is an open-label, international, multi-center, Phase 2 study in adult patients with recurrent, locally-advanced or metastatic solid tumors, which harbor the NRG1 gene fusion.

growth factor
total bilirubin
solid tumor
solid tumors
neutrophil count
  • 0 views
  • 09 Aug, 2021
  • 24 locations
A Study of ABL001 in Combination With Irinotecan or Paclitaxel in Patients With Advanced or Metastatic Solid Tumors

This study is a Phase 1b/2 multi-center study to assess the safety, tolerability, pharmacokinetics of ABL001 in combination with Irinotecan or Paclitaxel in patients with advanced or metastatic solid tumors.

  • 0 views
  • 21 Aug, 2021
  • 4 locations
A Trial Evaluating Surufatinib Efficacy and Safety in Biliary Tract Carcinoma Patients

This is a randomized, open-label, active-control, multi-center, phase IIb/III clinical study to evaluate the efficacy and safety of surufatinib vs. Capecitabine as a second-line therapy in patients with unresectable or metastatic biliary tract cancer (BTC). About 298 subjects are randomly assigned to two study treatment groups in the ratio of …

biliary tract carcinoma
capecitabine
progressive disease
cholangiocarcinoma
intrahepatic bile duct carcinoma
  • 9 views
  • 23 Jan, 2021
  • 1 location
A Study of ELI-002 in Subjects With KRAS Mutated Pancreatic Ductal Adenocarcinoma (PDAC) and Other Solid Tumor

This is a Phase 1/2 study to assess the safety and efficacy of ELI-002 immunotherapy (a lipid-conjugated immune-stimulatory oligonucleotide [Amph-CpG-7909] plus a mixture of lipid-conjugated peptide-based antigens [Amph-Peptides]) as adjuvant treatment of minimal residual disease (MRD) in subjects with KRAS/neuroblastoma ras viral oncogene homolog (NRAS) mutated PDAC or other solid …

NRAS
KRAS
cancer chemotherapy
  • 0 views
  • 22 Aug, 2021
  • 11 locations
Trial of Infusional FOLFIRINOX in First Line Treatment of Advanced Biliary Tract Cancers

This study is to evaluate the response rate and toxicity profile of infusional 5 fluorouracil, leucovorin, oxaliplatin and irinotecan (FOLFIRINOX) in first-line treatment of advanced biliary tract cancers and also to assess progression free survival and overall survival of FOLFIRINOX in first line treatment of advanced biliary tract cancers

biliary cancer
oxaliplatin
irinotecan
fluorouracil
leucovorin
  • 5 views
  • 06 Sep, 2021
  • 1 location